Openbookopenbook
Openbook
ARKG
-0.12 · -0.44%
$28.26 · BATS

ARK Genomic Revolution ETF (ARKG) ETF Analysis | Health

ARK ETF Trust · United States
AUM:$1.1B
#– of – in Health ETFs

Educational tool only – Figures are based on historical data, holdings and expense metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Market Performance

Up 28.1% over the past year, reflecting strong price momentum.

Cost Efficiency

Ongoing charge of 0.75% — moderate cost. Consider how fees compound over long holding periods.

What is ARKG?

The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).

Performance Highlights

Returns (%)
Top Sectors (%)

Investment Breakdown

Strong Recent Performance
ARKG delivered 28.1% over the past year. Historical returns only — past performance is not indicative of future results.
Moderate Cost
Expense ratio of 0.75%. Consider how fees compound over a long holding period.
Concentrated Holdings
Top 10 holdings account for 58.7% of the ETF — significant weight in a small number of names.
ETF Information
AUM$1.1B
Expense Ratio0.75%
Dividend Yield0.00%
Holdings29
Inception DateOct 2014
DomicileUnited States
DistributionNA
Index–
ProviderARK ETF Trust
Beta2.53
CategoryHealth
CurrencyUSD
Portfolio Impact

How would ARKG affect your portfolio?

Sign in to see exactly what adding this ETF changes — sector exposure, yield, diversification, volatility. Real numbers from your actual holdings.

Sign in
Example preview
6168
+7 points · better diversified

Chart Tools

My Portfolio

Sign in to overlay your portfolio on the chart.

Sign in
Compare Equity
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

6M
+58.9%
1Y
+92.4%
3Y
+49.0%
5Y
-43.5%
OpenBook InsightIf you had invested £10,000 in ARKG 5 years ago, it would have fallen to £5,646 — a loss of £4,354.

Annual Returns

Calendar year performance

ARKG delivered positive returns in 3 of the last 5 calendar years.
YearARKG
2026 YTD+63.3%
2025+18.4%
2024-28.0%
2023+18.8%
2022-55.4%
CAGR 4yr-18.0%
3/5 positive yearsAvg return: +3.4%Worst year: -55.4% (2022)

Technical Analysis Summary

Automated insights from historical price action and indicators

Technical Regime: POSITIVE
Trend Strength
100%
Positive
Volatility
49.1%
Very High
Momentum
+24.5%
30-day change
Support Level
39.62
Key floor
Key Insights
  • Price is currently trading above all key moving averages.
  • Momentum is upward with a 24.5% move over 30 days.
  • Elevated volatility indicates higher short-term price variability and risk.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.